# Pemetrexed and Oxaliplatin in Treating Patients With Locally Advanced Head and Neck Cancer

> **NCT00503997** · PHASE2 · COMPLETED · sponsor: **Vanderbilt-Ingram Cancer Center** · enrollment: 42 (actual)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **DRUG:** oxaliplatin
- **DRUG:** pemetrexed disodium

## Key facts

- **NCT ID:** NCT00503997
- **Lead sponsor:** Vanderbilt-Ingram Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2009-06
- **Final completion:** 2010-06
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2012-05-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00503997

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00503997, "Pemetrexed and Oxaliplatin in Treating Patients With Locally Advanced Head and Neck Cancer". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00503997. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*